As GLP-1 therapies become increasingly common, clinicians are facing new qestions about conception, pregnancy, fertility, breastfeeding, and postpartum care. This session delivers practical guidance for situations providers currently encounter. 

We'll discuss the following dilemmas:

• A patient conceived on semaglutide. How should we counsel her?
• Do currently available data support reassurance, additional surveillance, or both?
• What are experts recommending when evidence and guidelines don't fully align?
• How should GLP-1 therapy it into preconception care for patients with obesity, T2DM, and PMOS?
• When is it appropriate to restart GLP-1 treatment postpartum?
• How do breastfeeding goals influence management decisions?